Le Bastard N - Search Results

1

Increased CSF α-synuclein levels in Alzheimer's disease: correlation with tau levels.

Slaets S, Vanmechelen E, Le Bastard N, Decraemer H, Vandijck M, Martin JJ, De Deyn PP, Engelborghs S. Slaets S, et al. Among authors: le bastard n. Alzheimers Dement. 2014 Oct;10(5 Suppl):S290-8. doi: 10.1016/j.jalz.2013.10.004. Epub 2014 Jan 15. Alzheimers Dement. 2014. PMID: 24439167

2

LOW specificity limits the use of the cerebrospinal fluid AB1-42/P-TAU181P ratio to discriminate alzheimer's disease from vascular dementia.

Le Bastard N, Van Buggenhout M, De Leenheir E, Martin JJ, De Deyn PP, Engelborghs S. Le Bastard N, et al. J Gerontol A Biol Sci Med Sci. 2007 Aug;62(8):923-4; author reply 924-5. doi: 10.1093/gerona/62.8.923. J Gerontol A Biol Sci Med Sci. 2007. PMID: 17702886 No abstract available.

3

The dopaminergic neurotransmitter system is associated with aggression and agitation in frontotemporal dementia.

Engelborghs S, Vloeberghs E, Le Bastard N, Van Buggenhout M, Mariën P, Somers N, Nagels G, Pickut BA, De Deyn PP. Engelborghs S, et al. Among authors: le bastard n. Neurochem Int. 2008 May;52(6):1052-60. doi: 10.1016/j.neuint.2007.10.018. Epub 2007 Nov 4. Neurochem Int. 2008. PMID: 18093695

4

Reversal of head drop after discontinuation of olanzapine in a DLB patient.

Aries MJ, Debruyne H, Engelborghs S, Le Bastard N, Somers N, Gorissen D, Pickut BA, De Deyn PP. Aries MJ, et al. Among authors: le bastard n. Mov Disord. 2008 Sep 15;23(12):1760-2. doi: 10.1002/mds.22182. Mov Disord. 2008. PMID: 18661562

5

Is the geriatric depression scale a reliable screening tool for depressive symptoms in elderly patients with cognitive impairment?

Debruyne H, Van Buggenhout M, Le Bastard N, Aries M, Audenaert K, De Deyn PP, Engelborghs S. Debruyne H, et al. Among authors: le bastard n. Int J Geriatr Psychiatry. 2009 Jun;24(6):556-62. doi: 10.1002/gps.2154. Int J Geriatr Psychiatry. 2009. PMID: 19132643

6

Added diagnostic value of CSF biomarkers in differential dementia diagnosis.

Le Bastard N, Martin JJ, Vanmechelen E, Vanderstichele H, De Deyn PP, Engelborghs S. Le Bastard N, et al. Neurobiol Aging. 2010 Nov;31(11):1867-76. doi: 10.1016/j.neurobiolaging.2008.10.017. Epub 2009 Jan 15. Neurobiol Aging. 2010. PMID: 19150153

7

Improved discrimination of autopsy-confirmed Alzheimer's disease (AD) from non-AD dementias using CSF P-tau(181P).

Koopman K, Le Bastard N, Martin JJ, Nagels G, De Deyn PP, Engelborghs S. Koopman K, et al. Among authors: le bastard n. Neurochem Int. 2009 Sep;55(4):214-8. doi: 10.1016/j.neuint.2009.02.017. Epub 2009 Mar 5. Neurochem Int. 2009. PMID: 19524111

8

No correlation between time-linked plasma and CSF Abeta levels.

Le Bastard N, Aerts L, Leurs J, Blomme W, De Deyn PP, Engelborghs S. Le Bastard N, et al. Neurochem Int. 2009 Dec;55(8):820-5. doi: 10.1016/j.neuint.2009.08.006. Epub 2009 Aug 18. Neurochem Int. 2009. PMID: 19695299

9

Plasma amyloid-beta forms in Alzheimer's disease and non-Alzheimer's disease patients.

Le Bastard N, Leurs J, Blomme W, De Deyn PP, Engelborghs S. Le Bastard N, et al. J Alzheimers Dis. 2010;21(1):291-301. doi: 10.3233/JAD-2010-091501. J Alzheimers Dis. 2010. PMID: 20421698

10

Altered serum glycomics in Alzheimer disease: a potential blood biomarker?

Chen CC, Engelborghs S, Dewaele S, Le Bastard N, Martin JJ, Vanhooren V, Libert C, De Deyn PP. Chen CC, et al. Among authors: le bastard n. Rejuvenation Res. 2010 Aug;13(4):439-44. doi: 10.1089/rej.2009.0992. Rejuvenation Res. 2010. PMID: 20426627

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

41 results

Search Page

Filters